<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="27881">Resveratrol</z:chebi> is a natural <z:chebi fb="0" ids="26195">polyphenol</z:chebi> found in grapes and wine and has been associated with protective effects against <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular diseases</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>In vitro, both <z:chebi fb="0" ids="27881">resveratrol</z:chebi> preconditioning (RPC) and ischemic preconditioning (<z:chebi fb="76" ids="53004">IPC</z:chebi>) require activation of sirtuin 1 (SIRT1), a <z:chebi fb="0" ids="13389">nicotinamide adenine dinucleotide</z:chebi> (<z:chebi fb="0" ids="15846">NAD(+)</z:chebi>)-dependent deacetylase, to induce neuroprotection against <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>In the present study, we tested two hypotheses: (a) that neuroprotection against <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> can be induced by RPC in vivo; and (b) that RPC neuroprotection involves alterations in <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> function via the SIRT1 target <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> uncoupling protein 2 (UCP2) </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="76" ids="53004">IPC</z:chebi> was induced by 2 min of global <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> (temporary bilateral carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> with <z:hpo ids='HP_0002615'>hypotension</z:hpo>), and RPC, by i.p. injection of <z:chebi fb="0" ids="27881">resveratrol</z:chebi> at 10, 50 and 100 mg/kg dosages </plain></SENT>
<SENT sid="4" pm="."><plain>Forty-eight hours later, we compared the neuroprotective efficacy of RPC and <z:chebi fb="76" ids="53004">IPC</z:chebi> in vulnerable cornu ammonis 1 hippocampal pyramidal neurons using a rat model of asphyxial <z:hpo ids='HP_0001695'>cardiac arrest</z:hpo> (ACA) </plain></SENT>
<SENT sid="5" pm="."><plain>SIRT1 activity was measured using a SIRT1-specific fluorescent enzyme activity assay </plain></SENT>
<SENT sid="6" pm="."><plain>In hippocampal mitochondria isolated 48 h after <z:chebi fb="76" ids="53004">IPC</z:chebi> or RPC, we measured UCP2 levels, membrane potential, respiration, and the <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> ATP synthesis efficiency (<z:chebi fb="13" ids="16761">ADP</z:chebi>/O ratio) </plain></SENT>
<SENT sid="7" pm="."><plain>Both <z:chebi fb="76" ids="53004">IPC</z:chebi> and RPC induced tolerance against brain injury induced by <z:hpo ids='HP_0001695'>cardiac arrest</z:hpo> in this in vivo model </plain></SENT>
<SENT sid="8" pm="."><plain><z:chebi fb="76" ids="53004">IPC</z:chebi> increased SIRT1 activity at 48 h, while RPC increased SIRT1 activity at 1 h but not 48 h after treatment in hippocampus </plain></SENT>
<SENT sid="9" pm="."><plain><z:chebi fb="0" ids="27881">Resveratrol</z:chebi> significantly decreased UCP2 levels by 35% compared to sham-treated rats </plain></SENT>
<SENT sid="10" pm="."><plain>The SIRT1-specific inhibitor sirtinol abolished the neuroprotection afforded by RPC and the decrease in UCP2 levels </plain></SENT>
<SENT sid="11" pm="."><plain>Finally, RPC significantly increased the <z:chebi fb="13" ids="16761">ADP</z:chebi>/O ratio in hippocampal mitochondria reflecting enhanced ATP synthesis efficiency </plain></SENT>
<SENT sid="12" pm="."><plain>In conclusion, in vivo <z:chebi fb="0" ids="27881">resveratrol</z:chebi> pretreatment confers neuroprotection similar to <z:chebi fb="76" ids="53004">IPC</z:chebi> via the SIRT1-UCP2 pathway </plain></SENT>
</text></document>